Molecular Oncology
Volume 4, Issue 3 , Pages 267-283 , June 2010

Tracing the tumor lineage

  • Nicholas E. Navin

      Affiliations

    • Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA
    • Stony Brook University, Department of Molecular Genetics & Microbiology, Stony Brook, NY, USA
    • Corresponding Author InformationCorresponding author. Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA. Tel.: +1 508 564 0432/631 367 5067; fax: +1 631 367 8381.
    • ,
  • James Hicks

      Affiliations

    • Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA

Received 11 February 2010 ,Revised 23 April 2010 ,Accepted 23 April 2010.

References 

  1. Adams JM, Strasser A. Is tumor growth sustained by rare cancer stem cells or dominant clones?. Cancer Res. 2008;68:4018–4021
  2. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U S A. 2003;100:3983–3988
  3. Alkan C, Kidd JM, Marques-Bonet T, Aksay G, Antonacci F, Hormozdiari F, et al Personalized copy number and segmental duplication maps using next-generation sequencing. Nat. Genet. 2009;41:1061–1067
  4. Allred DC, Wu Y, Mao S, Nagtegaal ID, Lee S, Perou CM, et al. Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin. Cancer Res. 2008;14:370–378
  5. Aubele M, Mattis A, Zitzelsberger H, Walch A, Kremer M, Hutzler P, et al. Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. Cancer Genet. Cytogenet. 1999;110:94–102
  6. Aubele M, Werner M. Heterogeneity in breast cancer and the problem of relevance of findings. Anal. Cell Pathol. 1999;19:53–58
  7. Bachtiary B, Boutros PC, Pintilie M, Shi W, Bastianutto C, Li JH, et al Gene expression profiling in cervical cancer: an exploration of intratumor heterogeneity. Clin. Cancer Res. 2006;12:5632–5640
  8. Benetkiewicz M, Piotrowski A, Diaz De Stahl T, Jankowski M, Bala D, Hoffman J, et al. Chromosome 22 array-CGH profiling of breast cancer delimited minimal common regions of genomic imbalances and revealed frequent intra-tumoral genetic heterogeneity. Int. J. Oncol. 2006;29:935–945
  9. Bergamaschi A, Kim YH, Wang P, Sorlie T, Hernandez-Boussard T, Lonning PE, et al. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer. 2006;45:1033–1040
  10. Bielas JH, Loeb KR, Rubin BP, True LD, Loeb LA. Human cancers express a mutator phenotype. Proc. Natl. Acad. Sci. U S A. 2006;103:18238–18242
  11. Bielas JH, Loeb LA. Mutator phenotype in cancer: timing and perspectives. Environ. Mol. Mutagen. 2005;45:206–213
  12. Bilke S, Chen QR, Westerman F, Schwab M, Catchpoole D, Khan J. Inferring a tumor progression model for neuroblastoma from genomic data. J. Clin. Oncol. 2005;23:7322–7331
  13. Bockmuhl U, You X, Pacyna-Gengelbach M, Arps H, Draf W, Petersen I. CGH pattern of esthesioneuroblastoma and their metastases. Brain Pathol. 2004;14:158–163
  14. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997;3:730–737
  15. Brown TM, Fee E. Rudolf Carl Virchow: medical scientist, social reformer, role model. Am. J. Public Health. 2006;96:2104–2105
  16. Calza S, Hall P, Auer G, Bjohle J, Klaar S, Kronenwett U, et al Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res. 2006;8:R34
  17. Campbell PJ, Pleasance ED, Stephens PJ, Dicks E, Rance R, Goodhead I, et al. Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proc. Natl. Acad. Sci. U S A. 2008;105:13081–13086
  18. Campbell LL, Polyak K. Breast tumor heterogeneity: cancer stem cells or clonal evolution?. Cell Cycle. 2007;6:2332–2338
  19. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492–2502
  20. Chiang DY, Getz G, Jaffe DB, O’Kelly MJ, Zhao X, Carter SL, et al. High-resolution mapping of copy-number alterations with massively parallel sequencing. Nat. Methods. 2009;6:99–103
  21. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo WL, et al Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell. 2006;10:529–541
  22. Chin SF, Wang Y, Thorne NP, Teschendorff AE, Pinder SE, Vias M, et al Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers. Oncogene. 2007;26:1959–1970
  23. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, et al. Cancer stem cells–perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 2006;66:9339–9344
  24. Cole KA, Krizman DB, Emmert-Buck MR. The genetics of cancer–a 3D model. Nat. Genet. 1999;21:38–41
  25. Coons SW, Johnson PC, Shapiro JR. Cytogenetic and flow cytometry DNA analysis of regional heterogeneity in a low grade human glioma. Cancer Res. 1995;55:1569–1577
  26. Corver WE, Middeldorp A, ter Haar NT, Jordanova ES, van Puijenbroek M, van Eijk R, et al Genome-wide allelic state analysis on flow-sorted tumor fractions provides an accurate measure of chromosomal aberrations. Cancer Res. 2008;68:10333–10340
  27. Endoh Y, Tamura G, Kato N, Motoyama T. Apocrine adenosis of the breast: clonal evidence of neoplasia. Histopathology. 2001;38:221–224
  28. Fabian A, Barok M, Vereb G, Szollosi J. Die hard: are cancer stem cells the Bruce Willises of tumor biology?. Cytometry A. 2009;75:67–74
  29. Farabegoli F, Santini D, Ceccarelli C, Taffurelli M, Marrano D, Baldini N. Clone heterogeneity in diploid and aneuploid breast carcinomas as detected by FISH. Cytometry. 2001;46:50–56
  30. Fialkow PJ. The origin and development of human tumors studied with cell markers. N. Engl. J. Med. 1974;291:26–35
  31. Fitzgerald PJ. Homogeneity and heterogeneity in pancreas cancer: presence of predominant and minor morphological types and implications. Int. J. Pancreatol. 1986;1:91–94
  32. Fuhrmann C, Schmidt-Kittler O, Stoecklein NH, Petat-Dutter K, Vay C, Bockler K, et al. High-resolution array comparative genomic hybridization of single micrometastatic tumor cells. Nucleic Acids Res. 2008;36:e39
  33. Geigl JB, Obenauf AC, Waldispuehl-Geigl J, Hoffmann EM, Auer M, Hormann M, et al Identification of small gains and losses in single cells after whole genome amplification on tiling oligo arrays. Nucleic Acids Res. 2009;37:e105
  34. Giaretti W, Monaco R, Pujic N, Rapallo A, Nigro S, Geido E. Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: association with degree of DNA aneuploidy. Am. J. Pathol. 1996;149:237–245
  35. Glockner S, Buurman H, Kleeberger W, Lehmann U, Kreipe H. Marked intratumoral heterogeneity of c-myc and cyclinD1 but not of c-erbB2 amplification in breast cancer. Lab. Invest. 2002;82:1419–1426
  36. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70
  37. In:  Heim S,  Mittleman F editor. Cancer Cytogenetics. third ed.. John Wiley and Sons; 2009;ISBN 10:0-470-18179-6
  38. Heng HH, Bremer SW, Stevens J, Ye KJ, Miller F, Liu G, et al. Cancer progression by non-clonal chromosome aberrations. J. Cell Biochem. 2006;98:1424–1435
  39. Heng HH, Stevens JB, Liu G, Bremer SW, Ye KJ, Reddy PV, et al. Stochastic cancer progression driven by non-clonal chromosome aberrations. J. Cell Physiol. 2006;208:461–472
  40. Hicks J, Muthuswamy L, Krasnitz A, Navin N, Riggs M, Grubor V, et al High-resolution ROMA CGH and FISH analysis of aneuploid and diploid breast tumors. Cold Spring Harb. Symp. Quant. Biol. 2005;70:51–63
  41. Hicks J, Krasnitz A, Lakshmi B, Navin NE, Riggs M, Leibu E, et al Novel patterns of genome rearrangement and their association with survival in breast cancer. Genome Res. 2006;16:1465–1479
  42. Hirsch FR, Ottesen G, Podenphant J, Olsen J. Tumor heterogeneity in lung cancer based on light microscopic features. A retrospective study of a consecutive series of 200 patients, treated surgically. Virchows Arch. A Pathol. Anat. Histopathol. 1983;402:147–153
  43. Hoglund M, Gisselsson D, Hansen GB, Sall T, Mitelman F. Multivariate analysis of chromosomal imbalances in breast cancer delineates cytogenetic pathways and reveals complex relationships among imbalances. Cancer Res. 2002;62:2675–2680
  44. Hoglund M, Frigyesi A, Sall T, Gisselsson D, Mitelman F. Statistical behavior of complex cancer karyotypes. Genes Chromosomes Cancer. 2005;42:327–341
  45. Hovey RM, Chu L, Balazs M, DeVries S, Moore D, Sauter G, et al. Genetic alterations in primary bladder cancers and their metastases. Cancer Res. 1998;58:3555–3560
  46. Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, et al The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics. 2006;7:96
  47. Ignatiadis M, Sotiriou C. Understanding the molecular basis of histologic grade. Pathobiology. 2008;75:104–111
  48. Imle A, Polzer B, Alexander S, Klein CA, Friedl P. Genomic instability of micronucleated cells revealed by single-cell comparative genomic hybridization. Cytometry A. 2009;75:562–568
  49. Israeli O, Gotlieb WH, Friedman E, Korach J, Goldman B, Zeltser A, et al. Genomic analyses of primary and metastatic serous epithelial ovarian cancer. Cancer Genet. Cytogenet. 2004;154:16–21
  50. Jiang JK, Chen YJ, Lin CH, Yu IT, Lin JK. Genetic changes and clonality relationship between primary colorectal cancers and their pulmonary metastases–an analysis by comparative genomic hybridization. Genes Chromosomes Cancer. 2005;43:25–36
  51. Johann DJ, Rodriguez-Canales J, Mukherjee S, Prieto DA, Hanson JC, Emmert-Buck M, et al. Approaching solid tumor heterogeneity on a cellular basis by tissue proteomics using laser capture microdissection and biological mass spectrometry. J. Proteome Res. 2009;8:2310–2318
  52. Kallioniemi OP. Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. Cytometry. 1988;9:164–169
  53. Khalique L, Ayhan A, Weale ME, Jacobs IJ, Ramus SJ, Gayther SA. Genetic intra-tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours. J. Pathol. 2007;211:286–295
  54. Kim MY, Oskarsson T, Acharyya S, Nguyen DX, Zhang XH, Norton L, et al. Tumor self-seeding by circulating cancer cells. Cell. 2009;139:1315–1326
  55. Klein CA, Schmidt-Kittler O, Schardt JA, Pantel K, Speicher MR, Riethmüller G. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc. Natl. Acad. Sci. U S A. 1999;96:4494–4499
  56. Komaki K, Sano N, Tangoku A. Problems in histological grading of malignancy and its clinical significance in patients with operable breast cancer. Breast Cancer. 2006;13:249–253
  57. Kruger S, Thorns C, Bohle A, Feller AC. Prognostic significance of a grading system considering tumor heterogeneity in muscle-invasive urothelial carcinoma of the urinary bladder. Int. Urol. Nephrol. 2003;35:169–173
  58. Kwei KA, Kung Y, Salari K, Holcomb IN, Pollack JR. Genomic instability in breast cancer: Pathogenesis and clinical implications. Mol. Oncol. 2010;4(3):255–266
  59. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367:645–648
  60. Le Caignec C, Spits C, Sermon K, De Rycke M, Thienpont B, Debrock S, et al Single-cell chromosomal imbalances detection by array CGH. Nucleic Acids Res. 2006;34:e68
  61. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007;67:1030–1037
  62. Linder D, Gartler SM. Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas. Science. 1965;150:67–69
  63. Lips EH, van Eijk R, de Graaf EJ, Doornebosch PG, de Miranda NF, Oosting J, et al Progression and tumor heterogeneity analysis in early rectal cancer. Clin. Cancer Res. 2008;14:772–781
  64. Liu J, Bandyopadhyay N, Ranka S, Baudis M, Kahveci T. Inferring progression models for CGH data. Bioinformatics. 2009;25:2208–2215
  65. Liu W, Laitinen S, Khan S, Vihinen M, Kowalski J, Yu G, et al Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat. Med. 2009;15:559–565
  66. Loeb LA, Springgate CF, Battula N. Errors in DNA replication as a basis of malignant changes. Cancer Res. 1974;34:2311–2321
  67. Maley CC, Galipeau PC, Finley JC, Wongsurawat VJ, Li X, Sanchez CA, et al Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat. Genet. 2006;38:468–473
  68. Marusyk A, Polyak K. Tumor heterogeneity: causes and consequences. Biochim. Biophys. Acta. 2009;
  69. Matsumoto T, Fujii H, Arakawa A, Yamasaki S, Sonoue H, Hattori K, et al. Loss of heterozygosity analysis shows monoclonal evolution with frequent genetic progression and divergence in esophageal carcinosarcoma. Hum. Pathol. 2004;35:322–327
  70. Mitelman F, Johansson B, Mandahl N, Mertens F. Clinical significance of cytogenetic findings in solid tumors. Cancer Genet. Cytogenet. 1997;95:1–8
  71. Mora J, Cheung NK, Gerald WL. Genetic heterogeneity and clonal evolution in neuroblastoma. Br. J. Cancer. 2001;85:182–189
  72. Navin N, Krasnitz A, Rodgers L, Cook K, Meth J, Kendall J, et al Inferring tumor progression from genomic heterogeneity. Genome Res. 2010;20:68–80
  73. Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H. Clonal analysis of human breast cancer by means of the polymerase chain reaction. Cancer Res. 1992;52:6594–6597
  74. Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H. Clonal analysis of predominantly intraductal carcinoma and precancerous lesions of the breast by means of polymerase chain reaction. Cancer Res. 1994;54:1849–1853
  75. Norton L. Cancer stem cells, self-seeding, and decremented exponential growth: theoretical and clinical implications. Breast Dis. 2008;29:27–36
  76. Norton L, Massague J. Is cancer a disease of self-seeding?. Nat. Med. 2006;12:875–878
  77. Nowell PC. The clonal evolution of tumor cell populations. Science. 1976;194:23–28
  78. O’Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445:106–110
  79. Paget S. The distribution of secondary growths in cancer of the breast. Lancet. 1889;133:571–573
  80. Pandis N, Jin Y, Gorunova L, Petersson C, Bardi G, Idvall I, et al Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups. Genes Chromosomes Cancer. 1995;12:173–185
  81. Pantou D, Rizou H, Tsarouha H, Pouli A, Papanastasiou K, Stamatellou M, et al. Cytogenetic manifestations of multiple myeloma heterogeneity. Genes Chromosomes Cancer. 2005;42:44–57
  82. Pathare S, Schaffer AA, Beerenwinkel N, Mahimkar M. Construction of oncogenetic tree models reveals multiple pathways of oral cancer progression. Int. J. Cancer. 2009;124:2864–2871
  83. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al Molecular portraits of human breast tumours. Nature. 2000;406:747–752
  84. Podo F, Buydens LMC, Degani H, Hillhorst R, Klipp E, Gribbestad IS, et al Triple-negative breast cancer: Present challenges and new perspectives.. Mol. Oncol. 2010;4(3):209–229
  85. Polyak K. Breast cancer stem cells: a case of mistaken identity?. Stem Cell Rev. 2007;3:107–109
  86. Polyak K. Breast cancer: origins and evolution. J. Clin. Invest. 2007;117:3155–3163
  87. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. Efficient tumour formation by single human melanoma cells. Nature. 2008;456:593–598
  88. Rakha EA, Reis-Filho JS, Ellis IO. Basal-like breast cancer: a critical review. J. Clin. Oncol. 2008;26:2568–2581
  89. Roka S, Fiegl M, Zojer N, Filipits M, Schuster R, Steiner B, et al. Aneuploidy of chromosome 8 as detected by interphase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancer. Breast Cancer Res. Treat. 1998;48:125–133
  90. Sauter G, Moch H, Gasser TC, Mihatsch MJ, Waldman FM. Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer. Cytometry. 1995;21:40–46
  91. Sawada M, Azuma C, Hashimoto K, Noguchi S, Ozaki M, Saji F, et al. Clonal analysis of human gynecologic cancers by means of the polymerase chain reaction. Int. J. Cancer. 1994;58:492–496
  92. Selvarajah S, Yoshimoto M, Ludkovski O, Park PC, Bayani J, Thorner P, et al. Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH. Cytogenet. Genome Res. 2008;122:5–15
  93. Shackleton M, Quintana E, Fearon ER, Morrison SJ. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell. 2009;138:822–829
  94. Shah SP, Morin RD, Khattra J, Prentice L, Pugh T, Burleigh A, et al Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature. 2009;461:809–813
  95. Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, et al Molecular definition of breast tumor heterogeneity. Cancer Cell. 2007;11:259–273
  96. Shipitsin M, Polyak K. The cancer stem cell hypothesis: in search of definitions, markers, and relevance. Lab. Invest. 2008;88:459–463
  97. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396–401
  98. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al Gene expression patterns of carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U S A. 2001;98:10869–10874
  99. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. U S A. 2003;100:8418–8423
  100. Teixeira MR, Pandis N, Bardi G, Andersen JA, Mandahl N, Mitelman F, et al. Cytogenetic analysis of multifocal breast carcinomas: detection of karyotypically unrelated clones as well as clonal similarities between tumour foci. Br. J. Cancer. 1994;70:922–927
  101. Teixeira MR, Pandis N, Bardi G, Andersen JA, Mitelman F, Heim S. Clonal heterogeneity in breast cancer: karyotypic comparisons of multiple intra- and extra-tumorous samples from 3 patients. Int. J. Cancer. 1995;63:63–68
  102. Teixeira MR, Pandis N, Bardi G, Andersen JA, Heim S. Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer. Cancer Res. 1996;56:855–859
  103. Torres L, Ribeiro FR, Pandis N, Andersen JA, Heim S, Teixeira MR. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases. Breast Cancer Res. Treat. 2007;102:143–155
  104. Trent JM. Cytogenetic and molecular biologic alterations in human breast cancer: a review. Breast Cancer Res. Treat. 1985;5:221–229
  105. Tsarouha H, Pandis N, Bardi G, Teixeira MR, Andersen JA, Heim S. Karyotypic evolution in breast carcinomas with i(1)(q10) and der(1;16)(q10;p10) as the primary chromosome abnormality. Cancer Genet. Cytogenet. 1999;113:156–161
  106. van der Poel HG, Oosterhof GO, Schaafsma HE, Debruyne FM, Schalken JA. Intratumoral nuclear morphologic heterogeneity in prostate cancer. Urology. 1997;49:652–657
  107. Whelan S. Inferring trees. Methods Mol. Biol. 2008;452:287–309
  108. Zojer N, Fiegl M, Mullauer L, Chott A, Roka S, Ackermann J, et al Chromosomal imbalances in primary and metastatic pancreatic carcinoma as detected by interphase cytogenetics: basic findings and clinical aspects. Br. J. Cancer. 1998;77:1337–1342

PII: S1574-7891(10)00032-3

doi: 10.1016/j.molonc.2010.04.010

Molecular Oncology
Volume 4, Issue 3 , Pages 267-283 , June 2010

Article Tools

* Image Usage & Resolution